Moody's Puts Amsurg (AMSG) on Watch for Downgrade
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Raymond James Upgrades AmSurg (AMSG) to Strong Buy
May 30, 2014 6:59 AM EDTRaymond James upgraded AmSurg (NASDAQ: AMSG) from Market Perform to Strong Buy with a price target of $60.00.
For an analyst ratings summary and ratings history on AmSurg click here. For more ratings news on AmSurg click here.
Shares of AmSurg closed at $45.74 yesterday.
... MoreAmsurg (AMSG) to Acquire Sheridan Healthcare in $2.35B Deal
May 29, 2014 6:01 AM EDTAmsurg Corp (Nasdaq: AMSG) and Sheridan Healthcare, a portfolio company of Hellman & Friedman, LLC, today announced that their respective Boards of Directors have unanimously approved a definitive agreement under which AMSURG will acquire Sheridan Healthcare in a cash and stock transaction valued at approximately $2.35 billion. The transaction, which is subject to customary closing conditions and regulatory approvals, is expected to close in the third quarter of 2014.
AMSURG and Sheridan expect the combination to create a unique business model that will better meet critical needs for physicians, health systems, communities and payers. Sheridan Healthcare, a leading... More
